The CERT2 score was highly significant in predicting CVD mortality, yielding hazard ratios of 1.44 (1.28–1.63) in The Western Norway Coronary Angiography Cohort, 1.47 (1.34–1.61) in the LIPID trial, and 1.69 (1.31–2.17) in Langzeiterfolge der KARdiOLogischen Anschlussheilbehandlung.
1
—
—